Copyright Reports & Markets. All rights reserved.

Global Bicalutamide Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bicalutamide Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 14 Tablets Per Box
    • 1.3.3 28 Tablets Per Box
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bicalutamide Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Bicalutamide Tablets Market Size & Forecast
    • 1.5.1 Global Bicalutamide Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Bicalutamide Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Bicalutamide Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Bicalutamide Tablets Product and Services
    • 2.1.4 AstraZeneca Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Fosun Pharma
    • 2.2.1 Fosun Pharma Details
    • 2.2.2 Fosun Pharma Major Business
    • 2.2.3 Fosun Pharma Bicalutamide Tablets Product and Services
    • 2.2.4 Fosun Pharma Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fosun Pharma Recent Developments/Updates
  • 2.3 HISUN
    • 2.3.1 HISUN Details
    • 2.3.2 HISUN Major Business
    • 2.3.3 HISUN Bicalutamide Tablets Product and Services
    • 2.3.4 HISUN Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 HISUN Recent Developments/Updates
  • 2.4 FORWARD
    • 2.4.1 FORWARD Details
    • 2.4.2 FORWARD Major Business
    • 2.4.3 FORWARD Bicalutamide Tablets Product and Services
    • 2.4.4 FORWARD Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 FORWARD Recent Developments/Updates
  • 2.5 CordenPharma
    • 2.5.1 CordenPharma Details
    • 2.5.2 CordenPharma Major Business
    • 2.5.3 CordenPharma Bicalutamide Tablets Product and Services
    • 2.5.4 CordenPharma Bicalutamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CordenPharma Recent Developments/Updates

3 Competitive Environment: Bicalutamide Tablets by Manufacturer

  • 3.1 Global Bicalutamide Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Bicalutamide Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Bicalutamide Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Bicalutamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Bicalutamide Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Bicalutamide Tablets Manufacturer Market Share in 2025
  • 3.5 Bicalutamide Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Bicalutamide Tablets Market: Region Footprint
    • 3.5.2 Bicalutamide Tablets Market: Company Product Type Footprint
    • 3.5.3 Bicalutamide Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bicalutamide Tablets Market Size by Region
    • 4.1.1 Global Bicalutamide Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Bicalutamide Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Bicalutamide Tablets Average Price by Region (2021-2032)
  • 4.2 North America Bicalutamide Tablets Consumption Value (2021-2032)
  • 4.3 Europe Bicalutamide Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Bicalutamide Tablets Consumption Value (2021-2032)
  • 4.5 South America Bicalutamide Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Bicalutamide Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Bicalutamide Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Bicalutamide Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Bicalutamide Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Bicalutamide Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Bicalutamide Tablets Market Size by Country
    • 7.3.1 North America Bicalutamide Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Bicalutamide Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Bicalutamide Tablets Market Size by Country
    • 8.3.1 Europe Bicalutamide Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Bicalutamide Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Bicalutamide Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Bicalutamide Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Bicalutamide Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Bicalutamide Tablets Market Size by Country
    • 10.3.1 South America Bicalutamide Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Bicalutamide Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bicalutamide Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Bicalutamide Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Bicalutamide Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Bicalutamide Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Bicalutamide Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Bicalutamide Tablets Market Drivers
  • 12.2 Bicalutamide Tablets Market Restraints
  • 12.3 Bicalutamide Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bicalutamide Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bicalutamide Tablets
  • 13.3 Bicalutamide Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bicalutamide Tablets Typical Distributors
  • 14.3 Bicalutamide Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bicalutamide Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Bicalutamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Bicalutamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bicalutamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bicalutamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bicalutamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bicalutamide Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bicalutamide Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Fosun Pharma, HISUN, FORWARD, CordenPharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Bicalutamide Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    14 Tablets Per Box
    28 Tablets Per Box
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    AstraZeneca
    Fosun Pharma
    HISUN
    FORWARD
    CordenPharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Bicalutamide Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bicalutamide Tablets, with price, sales quantity, revenue, and global market share of Bicalutamide Tablets from 2021 to 2026.
    Chapter 3, the Bicalutamide Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bicalutamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bicalutamide Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bicalutamide Tablets.
    Chapter 14 and 15, to describe Bicalutamide Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now